Track topics on Twitter Track topics that are important to you
PeptiDream Inc., a Kanagawa-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today, the appointment of Dr. Kiyofumi Kaneshiro to the management team at Pep...
The latest biopharma industry appointments include C-suite hires at Hikma, Ipsen, Sinclair PeptiDream, Targovax, Nicox, Moderna, Antabio and Perrigo; as...
TOKYO and LONDON, May 24, 2018 /PRNewswire/ -- Peptide antagonists with high affinity and selectivity against PAR2 target identified Sosei Group Corporation ("Sosei" or the "Company"; TSE Mothers ...
Observers are weighing up whether it makes sense for Celgene to spend in the region of $12bn and plump for...
The coming of the new year has brought a flurry of executive changes. GSK Japan has a new president, Kyowa...
Glenmark is moving ahead with studies for its inhibitor of mPGES-1 amid cautious optimism. Pain management is, however, not a...
SummaryPeptiDream Inc PeptiDream is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptidedrug conjugate therapeutics. The company develops peptide d...
PeptiDream Inc. is a public (Tokyo Stock Exchange Mothers 4587) biopharmaceutical company founded in 2006 employing our proprietary Peptide Discovery Platform System (PDPS), a sta...
We have published hundreds of PeptiDream Inc. news stories on BioPortfolio along with dozens of PeptiDream Inc. Clinical Trials and PubMed Articles about PeptiDream Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PeptiDream Inc. Companies in our database. You can also find out about relevant PeptiDream Inc. Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...